Page last updated: 2024-09-03

bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Mouth Neoplasms

bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) has been researched along with Mouth Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calderwood-Mays, M; Fox, LE; Helfand, SC; King, RR; Kurzman, ID; Levine, PB; MacEwen, EG; Perez-Soler, R; Rosenthal, RC; Vail, DM1

Other Studies

1 other study(ies) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Mouth Neoplasms

ArticleYear
Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma.
    American journal of veterinary research, 2000, Volume: 61, Issue:7

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cat Diseases; Cats; Female; Infusions, Intravenous; Male; Mouth Neoplasms; Neoplasm Staging; Organoplatinum Compounds; Proportional Hazards Models; Prospective Studies; Radiography, Thoracic; Surveys and Questionnaires

2000